Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 5/20 | 0.36 |
| ▸ | MMP2 | P08253 | 5/20 | 0.36 |
| ▸ | MMP3 | P08254 | 5/20 | 0.36 |
| ▸ | MMP9 | P14780 | 5/20 | 0.36 |
| ▸ | MMP8 | P22894 | 5/20 | 0.36 |
| ▸ | IDE | P14735 | 8/20 | 0.35 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | REN | P00797 | 1/20 | 0.33 |
| ▸ | MLNR | O43193 | 1/20 | 0.33 |
| ▸ | CTSS | P25774 | 1/20 | 0.33 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.33 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.33 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20283589 | 0.93 | IDE (0.41) | IDEMEN1OPRM1OPRD1OPRK1 | |
| SCHEMBL20283427 | 0.92 | IDE (0.40) | IDEMEN1OPRM1OPRD1OPRK1 | |
| SCHEMBL24917456 | 0.92 | CTSS (0.34) | MMP1MMP2MMP3MMP9MMP8 | |
| SCHEMBL22916032 | 0.92 | GHSR (0.35) | MMP1MMP2MMP3MMP9MMP8 | |
| SCHEMBL24917527 | 0.91 | CTSS (0.34) | MMP1MMP2MMP3MMP9MMP8 | |
| SCHEMBL24917256 | 0.86 | OPRM1 (0.39) | MMP1MMP2MMP3MMP9MMP8 | |
| SCHEMBL20283426 | 0.86 | GHSR (0.39) | IDEMEN1MLNR | |
| SCHEMBL20283646 | 0.86 | IDE (0.34) | IDEPSMB5MEN1MLNRCTSS | |
| SCHEMBL20283428 | 0.85 | GHSR (0.34) | IDEPSMB5MLNRCTSSOPRM1 | |
| SCHEMBL22916085 | 0.85 | OPRM1 (0.42) | OPRM1OPRD1OPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210024476-A1 | Simplified Structural Mimetics of AIPS as Quorum Sensing Inhibitors | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2021-01-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210024476-A1 | Simplified Structural Mimetics of AIPS as Quorum Sensing Inhibitors | AIP, AIPL1, CGAS | MMP1 1820/4885MMP2 916/4885MMP3 1665/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.